Yale Program in Addiction Medicine

Starting soon! Join us for Addiction Medicine Grand Rounds today with Ismene Petrakis, MD.

medicine.yale.edu/internal-med...

The Weekly Update | Week of March 9th

🔗 view.message.yale.edu?vawpToken=OO...

Integrating Tobacco Treatment in HIV Care Yale School of Medicine's E. Jennifer Edelman, MD, MHS, tested an adaptive, team-based strategy to better integrate tobacco treatment into HIV clinics.

A new study from E. Jen Edelman et al tested an adaptive, team-based strategy to better integrate tobacco treatment into HIV clinics. Says Edelman, smoking must become a higher priority in HIV care + novel strategies can help patients live longer, healthier lives. medicine.yale.edu/internal-med...

Wonderful to see so many join us live for today's Addiction Medicine Grand Rounds on MOUD in pregnancy! Join us again, next week, when we'll be hearing from Yale Psychiatry's Ismene Petrakis, MD on PTSD in the setting of SUD treatment.

medicine.yale.edu/event/addict...

The Weekly Update | Week of March 2nd

🔗 view.message.yale.edu?vawpToken=XY...

Thanks to all 100+ of you who joined us for Addiction Medicine Grand Rounds, yesterday! We'll be back next week with a session on MOUD in pregnancy. Details @ the link below:

medicine.yale.edu/internal-med...

Curious about GLP-1s for substance use disorder treatment? Join us, tomorrow, for Addiction Medicine Grand Rounds with guest speaker, Dr. Joji Suzuki (@harvardmed.bsky.social).

🔗 medicine.yale.edu/internal-med...

The Weekly Update | Week of February 23rd

🔗 view.message.yale.edu?vawpToken=LU...

The Weekly Update | Week of February 16th

🔗 view.message.yale.edu?vawpToken=ED...

Emergency Department–Initiated Buprenorphine for Opioid Use Disorder This randomized clinical trial assesses the effect of emergency department (ED)–initiated 7-day extended-release injectable buprenorphine vs sublingual buprenorphine on treatment engagement at 7 days ...

(2/2) Read the full manuscript here: jamanetwork.com/journals/jam...

(1/2) A new study in @jama.com from @gaildonofrio.bsky.social et al found that 7-day injectable buprenorphine and daily tablet buprenorphine are equally safe and effective in engaging patients with opioid use disorder in treatment after an emergency department visit.

news.yale.edu/2026/02/11/s...

Thanks, all, who joined us for addiction medicine grand rounds, yesterday! We'll be back 2/24 with guest speaker, Dr. Joji Suzuki (@harvardmed.bsky.social), who will be speaking on GLP-1s. Hope to see you there!

medicine.yale.edu/event/addict...

Join us, today, at 12pm EST for Addiction Medicine Grand Rounds with @rnbluthenthal.bsky.social & Sid Ganesh (@keck.usc.edu, @uscpphs.bsky.social). Register @ the link below.

medicine.yale.edu/internal-med...

The Weekly Update | Week of February 9th

🔗 view.message.yale.edu?vawpToken=VH...

Moderate Drinking: What Are the Benefits and Risks? Studies have shown that moderate drinking can impact health in numerous ways. So is it safe or not? Experts weigh in.

Recent research on alcohol’s effect on heart disease, cancer, & the brain has prompted changes from major health organizations + societies. If you’re fuzzy on how to drink responsibly, that's understandable. Dr. Steve Holt (@YaleIMed) & others weigh in: www.everydayhealth.com/diet-nutriti...

Methadone: Public Transit is a Barrier for Accessing Treatment In a new study published in JAMA Network Open, Yale researchers examined the burdens for people who use public transit to access methadone treatment for opioid

New in @jamanetworkopen.com, @howellben.bsky.social et al highlight notable disparities in public transit access to #methadone treatment for OUD in Connecticut.
medicine.yale.edu/internal-med...

@gregggonsalves.bsky.social @emmabiegacki.bsky.social @yalesph.bsky.social @yaleschoolofmed.bsky.social

The Weekly Update | Week of February 3rd

🔗 view.message.yale.edu?vawpToken=XT...

National Methadone Access and Quality Commission Established to Improve Access To High-Quality, Patient-Centered, Evidence-Based Treatment for OUD - FORE FORE has awarded a grant of $917,027 to Yale University to establish the National Methadone Access and Quality Commission (NMAQC), a new national initiative focused on improving access to methadone, a...

The Foundation for Opioid Response Efforts has awarded a grant to Yale University to establish the National Methadone Access and Quality Commission, a new national initiative focused on improving access to methadone for the treatment of opioid use disorder. Read more: forefdn.org/national-met...

Thanks all who joined us, today, for Addiction Med Grand Rounds w/ Sandra Springer! A recording will be available online, soon! Coming up in February, we'll be joined by @rnbluthenthal.bsky.social & Sid Ganesh (@keck.usc.edu). Register @ the link below.

🔗 medicine.yale.edu/internal-med...

The Weekly Update | Week of January 26th

🔗 view.message.yale.edu?vawpToken=IQ...

Coming up, next week, join us for Addiction Medicine Grand Rounds with Sandra Springer, MD! We hope to see you there.

medicine.yale.edu/internal-med...

Project Manager, Addiction Medicine in New Haven, Connecticut, 06511 | Other at Yale University Apply for Project Manager, Addiction Medicine job with Yale University in New Haven, Connecticut, 06511. Other at Yale University

💼 We're hiring! YPAM is seeking an Addiction Medicine Project Manager. You'll support a diverse portfolio of multidisciplinary projects spanning research, education, policy, clinical practice, & community engagement. Come join a dynamic, growing program! careers.yale.edu/us/en/job/13...

🎉 Congratulations to our program director, Dr. David Fiellin, who has been named a Distinguished Fellow of the American Society of Addiction Medicine. www.asam.org/news/detail/...

The Weekly Update | Week of January 19th

🔗 view.message.yale.edu?qs=3c41335ea...

The Weekly Update | Week of January 12th

🔗 view.message.yale.edu?qs=a328a517c...

Medicaid reimbursement boosts access to opioid treatment at new facilities Yale School of Public Health researchers say that a dramatic increase in the use of opioid disorder medications in residential treatment facilities over the

Medicaid reimbursement boosts access to opioid treatment at new facilities, but Yale study led by
@tamarabeetham.bsky.social & colleagues finds that existing facilities lag, providing important insights for policymakers looking to improve access to and quality of care.
ysph.yale.edu/news-article...

The Weekly Update | Week of January 5th
#HappyNewYear2026

🔗 view.message.yale.edu?qs=09ffb6ada...

Can weed help you drink less? Scientists study how well 'California sober' works It's trendy in some circles to replace drinking with consuming cannabis. But can it help people with a drinking problem cut back? Scientists set up a bar in the lab to find out.

"New research offers some of the strongest data yet suggesting that smoking weed does, at least in the short term, curb how much people drink." @npr.org spoke with Rajita Sinha, PhD, and others about the potential role of cannabis in alcohol reduction. www.npr.org/sections/sho...

Medicaid reimbursement boosts access to opioid treatment Yale School of Public Health researchers say that a dramatic increase in the use of opioid disorder medications in residential treatment facilities over the

Medicaid Reimbursement Boosts Access to Opioid Treatment: Yale Study Provides Important Insights for Policymakers Looking to Improve Access to Addiction Treatment and Quality of Care
ysph.yale.edu/news-article...

The Weekly Update | Week of December 22nd
The Weekly Update will return in 2026!

🔗 view.message.yale.edu?qs=fbdb0f5c7...